Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
226 words
A method for determining the presence or absence of each of a predetermined number of different ligands selected from one or two ligands in a liquid, semi-liquid or pasty specimen, by a direct or indirect agglutination, or an agglutination inhibition method by competition, comprising the steps: contacting the specimen with a predetermined number of homogeneous populations of fluorescent beads, each population having a specific fluorescence and having one or more predetermined antiligands fixed to their surface, said predetermined number of populations being equal to said predetermined number of ligands; analyzing said specimen containing said beads using a measuring means capable of discriminating between the specific fluorescence of said beads for each ligand, said measuring means being selected from the group consisting of a flow cytometer, an image analyzer and a laser sweep system; determining in response to said analyzing step the number of non-agglutinated beads, the number of agglutinated beads, the number of bead aggregates and for each aggregate, the number of the beads it comprises, by absolute measurement of the intensity and the fluorescence wavelength of each particle or aggregate of particles, one by one; and correlating the information determined in said determining step with the presence or absence in said specimen, of each of said different ligands to thereby enable the simultaneous determination of a plurality of ligands using a single bead contacting step.
Claim 2
Independent Claim
226 words
A method for determining the presence or absence of each of a predetermined number of different ligands selected from one or two ligands in a liquid, semi-liquid or pasty specimen, by a direct or indirect agglutination, or an agglutination inhibition method by competition, comprising the steps: contacting the specimen with a predetermined number of homogeneous populations of fluorescent beads, each population having a specific fluorescence and having one or more predetermined antiligands fixed to their surface, said predetermined number of populations being equal to said predetermined number of ligands; analyzing said specimen containing said beads using a measuring means capable of discriminating between the specific fluorescence of said beads for each ligand, said measuring means being selected from the group consisting of a flow cytometer, an image analyzer and a laser sweep system; determining in response to said analyzing step the number of non-agglutinated beads, the number of agglutinated beads, the number of bead aggregates and for each aggregate, the number of the beads it comprises, by absolute measurement of the intensity and the fluorescence wavelength of each particle or aggregate of particles, one by one; and correlating the information determined in said determining step with the presence or absence in said specimen, of each of said different ligands to thereby enable the simultaneous determination of a plurality of ligands using a single bead contacting step.
Claim 3
Dependent Claim
19 words
The method according to claim 1, wherein said beads comprise at least two predetermined antiligands fixed to their surface.
Claim 4
Dependent Claim
19 words
The method according to claim 1, wherein said beads have a diameter of between 0.05 μm and 10 μm.
Claim 5
Dependent Claim
43 words
The method according to claim 1, wherein said antiligand is selected from the group consisting of antigens, antibodies, receptors, lectins, proteins of type A or G, and avidin, said antiligand being specific to one or more of said predetermined number of different ligands.
Claim 6
Dependent Claim
12 words
The method according to claim 4, wherein the antibodies are monoclonal antibodies.
Claim 7
Dependent Claim
12 words
The method according to claim 4, wherein the antibodies are polyclonal antibodies.
Claim 8
Dependent Claim
24 words
The method according to claim 1 wherein said correlating step is conducted in a manner to determine quantitative values for each of said ligands.
Claim 9
Independent Claim
222 words
A method for determining the presence or absence of each two different ligands in a liquid, semi-liquid or pasty specimen, by a direct or indirect agglutination, or an agglutination inhibition method by competition, comprising the steps of: contacting the specimen with a predetermined plurality of homogeneous populations of fluorescent beads, each population having a specific fluorescence and having one or more predetermined antiligands fixed to their surface, said predetermined plurality of populations being two populations; analyzing said specimen containing said beads using a measuring means capable of discriminating between the specific fluorescence of said beads for each ligand, said measuring means being selected from the group consisting of a flow cytometer, an image analyzer and a laser sweep system; determining in response to said analyzing step, the number of non-agglutinated beads, the number of agglutinated beads, the number of bead aggregates and for each aggregate, the number of the beads it comprises and the population type or types of beads it comprises, by absolute measurement of the intensity and the fluorescence wavelength of each particle or aggregate of particles, one by one; and correlating the information determined in said determining step with the presence or absence in said specimen of each of said different ligands to thereby enable the simultaneous determination of a plurality of ligands using a single bead contacting step.
Claim 10
Independent Claim
222 words
A method for determining the presence or absence of each two different ligands in a liquid, semi-liquid or pasty specimen, by a direct or indirect agglutination, or an agglutination inhibition method by competition, comprising the steps of: contacting the specimen with a predetermined plurality of homogeneous populations of fluorescent beads, each population having a specific fluorescence and having one or more predetermined antiligands fixed to their surface, said predetermined plurality of populations being two populations; analyzing said specimen containing said beads using a measuring means capable of discriminating between the specific fluorescence of said beads for each ligand, said measuring means being selected from the group consisting of a flow cytometer, an image analyzer and a laser sweep system; determining in response to said analyzing step, the number of non-agglutinated beads, the number of agglutinated beads, the number of bead aggregates and for each aggregate, the number of the beads it comprises and the population type or types of beads it comprises, by absolute measurement of the intensity and the fluorescence wavelength of each particle or aggregate of particles, one by one; and correlating the information determined in said determining step with the presence or absence in said specimen of each of said different ligands to thereby enable the simultaneous determination of a plurality of ligands using a single bead contacting step.
Claim 11
Dependent Claim
28 words
The method according to claim 8 wherein the beads in at least one of said homogenous populations of beads comprise at least two antiligands affixed to their surface.
Claim 12
Dependent Claim
19 words
The method according to claim 8 wherein said beads have a diameter of between 0.05 μm and 10 μm.
Claim 13
Dependent Claim
49 words
The method according to claim 8 wherein the antiligands fixed to the surface of said beads are specific to one or more of said predetermined plurality of different ligands and are selected from the group consisting of antigens, antibodies, receptors, lectins, proteins of type A or G, or avidin.
Claim 14
Dependent Claim
12 words
The method according to claim 11 wherein the antibodies are monoclonal antibodies.
Claim 15
Dependent Claim
12 words
The method according to claim 11 wherein the antibodies are polyclonal antibodies.
Claim 16
Dependent Claim
24 words
The method according to claim 8 wherein said correlating step is conducted in a manner to determine quantitative values for each of said ligands.